4 questions on President Trump and IVF

As part of our “4 questions with” series for Second Opinion VIP subs, I was eager to learn more about President Trump’s recent Executive Order to “expand access to” in vitro fertilization, or IVF.

How significant is it? Is there any real policy heft behind it? And if you’d like to gain access to IVF and can’t afford it, what does this mean for you? To get answers, I pulled aside Joshua Abram, co-founder of Conceivable Life Sciences (and a Scrub Capital portfolio company), to discuss.

Joshua has worked for several decades in the fertility industry, first as cofounder of TMRW Life Sciences, which helps clinics better store frozen eggs and embryos. Conceivable goes even further, by automating the embryology lab, with the goal of improving precision and bringing down the cost of assisted reproduction treatments.

This interview has been edited for brevity.

Second Opinion: What did you make of President Trump’s executive order to expand IVF access? Is there any actual policy behind it?

Subscribe to VIP Membership to read the rest.